This site is intended for health professionals only

BNPs “strong” markers in CAD

teaser

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) provide strong and incremental prognostic information in combination with traditional risk factors in low-risk patients with stable coronary artery disease (CAD) and preserved left ventricular (LV) function, PEACE study findings show.

The association between BNPs and survival has been well documented in a wide spectrum of cardiovascular diseases, according to Dr Torbj






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x